Table 1

Baseline characteristic of the first 100 patients in the ASSessing the effect of Anti-IL-6 study

Demography
Age, years (range)61.0±8.7 (38–79)
Male gender, n (%)80 (80.0)
Race/ethnicity, n (%)
 White/Black/Asian96 (96.0)/0 (0.0)/4 (4.0)
Relationship status, n (%)
 Married/single/widow(er)73 (73.0)/22 (22.0)/5 (5.0)
Work status, n (%)
 Working/sick leave/pensioner61 (61.0)/4 (4.0)/34 (34.0)
Cardiovascular risk factors, n (%)
 Current smoker/former smoker40 (40.0)/26 (26.0)/34 (34.0)
 Hypertension33 (33.0)
 Diabetes mellitus7 (7.0)
 Peripheral vascular disease2 (2.0)
Chest pain to hospital arrival time, hours (range)2.4±1.2 (0.42–6.0)
Concomitant medication, n (%)
 ACE-inhibitor/angiotensin receptor blocker26 (26)
 Aldosterine antagonist1 (1)
 Anticoagulants4 (4)
 Antiplatelets10 (10)
 Beta blocker7 (7)
 Calcium antagonist14 (14)
 Diuretics10 (10)
 Statin10 (10)
 Other25 (25)
Clinical characteristics
Blood pressure, mm Hg (range)
 Systolic132.3±21.5 (80.0–180.0)
 Diastolic82.7±16.2 (50.0–121.0)
Heart rate, beats per minute (range)70.8±16.1 (40.0–125.0)
Body mass index, kg/m2 (range)27.0 (15.7–39.2)±4.3
Killip classification, n (%)
 I/II/III/IV95 (95)/4 (4)/0 (0)/0 (0)
New York Heart Association functional status, n (%)
 I/II/III/IV62 (62)/27 (27)/3 (3)/7 (7)
  • Data are given as number (percent) or mean±SD (range)